Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Phase of Trial: Phase II
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Lipodystrophy
- Focus Pharmacodynamics
- 21 Sep 2016 Status changed from not yet recruiting to recruiting.
- 12 Jan 2016 Planned initiation date changed from 1 Jun 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
- 07 May 2015 New trial record